IV SafeLock Device Functionality in Emergency Department
NCT05695183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-10-10
Summary
The purpose of this research study is to evaluate the functionality of the IV SafeLock in the clinical emergency department setting.
Conditions
- Intravenous Access
Interventions
- DEVICE
-
IV SafeLock
Designed to prevent patient access to intravenous lines in the hospital setting. The device locks with an institution specific key and protects the hub as well as all tubing access points.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kara Bragg, APRN, DNP · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-22
- Primary Completion
- 2023-10-06
- Completion
- 2023-10-06
Countries
- United States
Study Locations
More Related Trials
-
AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)
NCT01937195 ·Status: COMPLETED ·Phase: NA
-
Cardiac Arrest and Intra Osseous Infusion
NCT01803971 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population
NCT03505957 ·Status: COMPLETED ·Phase: NA
-
Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition
NCT02255318 ·Status: UNKNOWN ·Phase: NA
-
Maintaining Patency in Implanted Port Catheters
NCT02354118 ·Status: COMPLETED ·Phase: NA
-
Survey of Practices Regarding the Use of Taurolidine Lock Solutions in Patients With Insertion of a Peripherally Inserted Central Catheter (PICC) in a Vascular Access Unit
NCT07259421 ·Status: NOT_YET_RECRUITING
-
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
NCT02095951 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Ethanol Lock Therapy Study.
NCT00948441 ·Status: COMPLETED ·Phase: NA
-
Study of the Use of Coated Venous Catheters in the Critically Ill Child
NCT00202813 ·Status: COMPLETED ·Phase: PHASE4
-
Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
NCT02923830 ·Status: TERMINATED ·Phase: PHASE4
-
Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization
NCT01305681 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Does a Novel Needle Over Catheter Device Improve First Pass Success and Decrease Complications
NCT06547294 ·Status: SUSPENDED ·Phase: NA
-
Safe-Infusion Study
NCT06727240 ·Status: RECRUITING ·Phase: NA
-
Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
NCT00994136 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter
NCT02453646 ·Status: COMPLETED ·Phase: NA
-
Ethanol Locks for the Treatment of Central Venous Line Infections
NCT00680459 ·Status: TERMINATED ·Phase: PHASE3
-
Registry AutoLog Lipid Removal and Blood Component Characterization
NCT01565967 ·Status: COMPLETED
-
Flow Arrest Safety and Technical Success With Balloon Guide Catheters
NCT04416659 ·Status: COMPLETED
-
ThrombX Retriever for Acute Ischemic Stroke Trial
NCT05270122 ·Status: UNKNOWN ·Phase: NA
-
Ethanol Lock for the Salvage of Infected Long-term Vascular Access
NCT01186172 ·Status: UNKNOWN ·Phase: PHASE3
-
SecurAcath Versus Statlock for PICC Securement
NCT02311127 ·Status: COMPLETED ·Phase: NA
-
Improving Safety of Lead Extraction Procedures by Traction Force Sensing
NCT03842124 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections
NCT06660641 ·Status: COMPLETED ·Phase: NA
-
Transillumination to Reduce Post-injection Complications in Aesthetic Medicine
NCT04750421 ·Status: COMPLETED ·Phase: NA
-
Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?
NCT00749619 ·Status: COMPLETED ·Phase: PHASE3